Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 2
2019 2
2020 4
2021 1
2022 2
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.
Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, Hexner EO, Rösler W, Etra AM, Sandhu K, Yanik GA, Chanswangphuwana C, Kitko CL, Reshef R, Kraus S, Wölfl M, Eder M, Bertrand H, Qayed M, Merli P, Grupp SA, Aguayo-Hiraldo P, Schechter T, Ullrich E, Baez J, Beheshti R, Gleich S, Kowalyk S, Morales G, Young R, Kwon D, Nakamura R, Levine JE, Ferrara JLM, Chen YB. Akahoshi Y, et al. Among authors: choe hk. Blood Adv. 2023 Aug 22;7(16):4479-4491. doi: 10.1182/bloodadvances.2023009885. Blood Adv. 2023. PMID: 37315175 Free PMC article.
Dupilumab for refractory sclerotic-type cutaneous graft-versus-host disease.
Mital R, Penza SL, Choe HK, Chung CG, Kaffenberger BH. Mital R, et al. Among authors: choe hk. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1323-e1324. doi: 10.1111/jdv.19311. Epub 2023 Jul 10. J Eur Acad Dermatol Venereol. 2023. PMID: 37416952 No abstract available.
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.
Akahoshi Y, Spyrou N, Hoepting M, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Grupp SA, Hexner EO, Hogan WJ, Kitko CL, Kraus S, Al Malki MM, Merli P, Qayed M, Reshef R, Schechter T, Ullrich E, Vasova I, Wölfl M, Zeiser R, Baez J, Beheshti R, Eng G, Gleich S, Kasikis S, Katsivelos N, Kowalyk S, Morales G, Young R, DeFilipp Z, Ferrara JLM, Levine JE, Nakamura R. Akahoshi Y, et al. Among authors: choe hk. Blood Adv. 2024 Apr 23;8(8):2047-2057. doi: 10.1182/bloodadvances.2023012091. Blood Adv. 2024. PMID: 38324721 Free PMC article.
Donor graft genotypes versus leukemia.
Choe HK, van Besien K. Choe HK, et al. Leuk Lymphoma. 2019 Jul;60(7):1606-1607. doi: 10.1080/10428194.2019.1613542. Leuk Lymphoma. 2019. PMID: 31238818 No abstract available.
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.
Gergoudis SC, DeFilipp Z, Özbek U, Sandhu KS, Etra AM, Choe HK, Kitko CL, Ayuk F, Aziz M, Baez J, Ben-David K, Bunworasate U, Gandhi I, Hexner EO, Hogan WJ, Holler E, Kasikis S, Kowalyk SM, Lin JY, Merli P, Morales G, Nakamura R, Reshef R, Rösler W, Srinagesh H, Young R, Chen YB, Ferrara JLM, Levine JE. Gergoudis SC, et al. Among authors: choe hk. Blood Adv. 2020 Dec 22;4(24):6098-6105. doi: 10.1182/bloodadvances.2020003336. Blood Adv. 2020. PMID: 33351103 Free PMC article. Clinical Trial.
Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study.
Holtan SG, Yu J, Paranagama D, Tang J, Choe HK, Naim A, Joachim Deeg H, Galvin J. Holtan SG, et al. Among authors: choe hk. Bone Marrow Transplant. 2022 Sep;57(9):1399-1404. doi: 10.1038/s41409-022-01736-0. Epub 2022 Jun 23. Bone Marrow Transplant. 2022. PMID: 35739326 Free PMC article.
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome.
Kittai AS, Bond DA, William B, Saad A, Penza S, Efebera Y, Larkin K, Wall SA, Choe HK, Bhatnagar B, Vasu S, Brammer J, Shindiapina P, Long M, Mims A, O'Donnell L, Bhat SA, Rogers KA, Woyach JA, Byrd JC, Jaglowski SM. Kittai AS, et al. Among authors: choe hk. Blood Adv. 2020 Oct 13;4(19):4648-4652. doi: 10.1182/bloodadvances.2020002783. Blood Adv. 2020. PMID: 33002129 Free PMC article. No abstract available.
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.
Snyder KJ, Zitzer NC, Gao Y, Choe HK, Sell NE, Neidemire-Colley L, Ignaci A, Kale C, Devine RD, Abad MG, Pietrzak M, Wang M, Lin H, Zhang YW, Behbehani GK, Jackman JE, Garzon R, Vaddi K, Baiocchi RA, Ranganathan P. Snyder KJ, et al. Among authors: choe hk. JCI Insight. 2020 Apr 23;5(8):e131099. doi: 10.1172/jci.insight.131099. JCI Insight. 2020. PMID: 32191634 Free PMC article.
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant.
Aziz MD, Shah J, Kapoor U, Dimopoulos C, Anand S, Augustine A, Ayuk F, Chaudhry M, Chen YB, Choe HK, Etra A, Gergoudis S, Hartwell MJ, Hexner EO, Hogan WJ, Kitko CL, Kowalyk S, Kröger N, Merli P, Morales G, Nakamura R, Ordemann R, Pulsipher MA, Qayed M, Reshef R, Rösler W, Schechter T, Schreiner E, Srinagesh H, Wölfl M, Wudhikarn K, Yanik G, Young R, Özbek U, Ferrara JLM, Levine JE. Aziz MD, et al. Among authors: choe hk. Leukemia. 2020 Jul;34(7):1898-1906. doi: 10.1038/s41375-020-0726-z. Epub 2020 Feb 4. Leukemia. 2020. PMID: 32020045 Free PMC article.
19 results